FTC Report Poised to Spur New Legal Challenges in Insulin Pricing Debate

The recent Federal Trade Commission (FTC) report is expected to significantly impact ongoing legal battles surrounding insulin pricing. Miami attorney Tal Lifshitz noted, “The report will inevitably lead to more lawsuits,” suggesting that the findings may serve as a catalyst for increased litigation concerning insulin manufacturers. For additional information on this developing issue, visit the report’s overview. As the legal community scrutinizes the FTC’s findings, further actions could reshape the landscape of insulin pricing and accessibility.